All In Biotech

Drug safety

How to check whether a drug is in shortage: FDA and ASHP lists

How to check the FDA drug shortage list and other drug shortage databases, what each status means, and why FDA and ASHP counts differ. Free, official sources.

By the All In Biotech editorial team · Published November 18, 2026 · 5 min read

To check whether a drug is in shortage in the United States, search FDA's Drug Shortages Database by generic name, then compare it with the ASHP current shortages list. FDA's list shows shortages it has confirmed at the national level. ASHP's list is broader and often shows supply problems earlier.

Both lists are free and need no account. The sections below explain where each list comes from, what the statuses mean, and how to read an entry at the level of a single product.

What counts as a drug shortage

Federal law defines a drug shortage as a period when demand or projected demand for a drug in the United States exceeds its supply. That definition sits in section 506C of the Federal Food, Drug, and Cosmetic Act, which also requires manufacturers of certain drugs to tell FDA about a permanent discontinuance or an interruption in manufacturing that is likely to disrupt supply. The notice is due at least six months in advance or, if that is not possible, as soon as practicable.

FDA's drug shortages page explains how the agency works with manufacturers once it learns of a problem. Common causes include manufacturing and quality problems, delays, discontinuations and sudden increases in demand.

A shortage is a national supply question. A single pharmacy being out of stock is not, by itself, a shortage in FDA's sense.

The main places to check

FDA Drug Shortages Database

FDA's database is the official federal list. Each entry names the drug, its status, the affected presentations, the reason given, and often an estimated recovery date supplied by the manufacturer. FDA also lists discontinuations here.

Use it when you need the federal position, for example to see whether a drug is formally listed as in shortage.

ASHP drug shortages list

The American Society of Health-System Pharmacists maintains its own list, with drug information support from the University of Utah. ASHP takes reports from clinicians and pharmacies and lists a drug when a supply problem affects how it is prepared or dispensed, or affects patient care. Its entries often include notes on available products and alternative presentations.

Because the criteria differ, ASHP's count of active shortages is usually higher than FDA's. Neither list is wrong. They answer slightly different questions.

openFDA drug shortages endpoint

FDA also publishes its shortage data through the openFDA drug shortages API. Records are kept at the level of the package NDC, so one drug can appear many times, once for each affected strength or package. When this site queried the endpoint on November 18, 2026, it held 1,584 records: 1,116 with status Current, 409 with status To Be Discontinued and 59 with status Resolved. These are product records, not a count of distinct drugs.

This site's drug pages

Each drug page on All In Biotech pulls the openFDA shortage records that match that application and shows the status and the affected presentation next to the approval history and label.

What the statuses mean

The openFDA records use three statuses:

  • Current: the shortage is active for that presentation.
  • To Be Discontinued: the manufacturer has told FDA it will stop making that product. A discontinuation can cause a shortage if no other supplier fills the gap, but it is a separate situation.
  • Resolved: FDA has determined that supply now meets demand for that entry.

FDA's database may also show related details such as the reason for the shortage and an estimated resupply date. Recovery dates come from manufacturers and often move, so treat them as estimates.

How to read a shortage entry

A shortage almost never covers every version of a drug at once. When you read an entry, check these fields:

  1. Generic name and dosage form. An injectable may be short while the oral form of the same ingredient is not.
  2. Strength and package NDC. One vial size can be unavailable while others ship normally.
  3. Manufacturer. If several companies make the drug, one may be affected and the others not.
  4. Reason. Manufacturing delays, increased demand and discontinuation each suggest a different outlook.
  5. Dates. The initial posting date tells you how long the problem has been listed. The last update shows whether the entry is being maintained.

If you are comparing FDA and ASHP, match on generic name and dosage form first, then on strength.

Shortages, compounding and the GLP-1 example

A shortage listing has consequences beyond supply. While a drug is on FDA's shortage list, federal law gives compounding pharmacies and outsourcing facilities more room to make copies of it. When FDA declares the shortage resolved, that room narrows again.

The best-known recent case involved the GLP-1 drugs semaglutide and tirzepatide. Both were listed in shortage during a period of very high demand, and FDA later declared both shortages resolved. FDA's page on medications containing semaglutide explains its position on compounded and unapproved versions. For the approved products and their Medicare spending, see every FDA-approved GLP-1 drug and what Medicare spends on them.

Shortages and recalls are different things

A recall removes or corrects a product that violates FDA rules. A shortage is a supply problem. The two can be linked, since a large recall can take enough product off the market to cause a shortage, but most shortages have other causes and most recalls do not cause shortages.

Drug pages on this site show both: recalls from FDA enforcement reports and shortages from the shortage database. For more on how recalls are classified, read drug recall classes explained.

A practical checklist

When someone asks whether a drug is in shortage, this sequence covers the main sources:

  1. Search the generic name in FDA's Drug Shortages Database and note the status and affected presentations.
  2. Search the same name on the ASHP list for practitioner reports and notes on available products.
  3. Open the drug's page on /drugs to see the openFDA shortage records next to the approval history, label and any recalls.
  4. Check whether the entry is a discontinuation rather than a temporary shortage.
  5. Check the posting and update dates, and come back later, since shortage status changes often.

Limits of the data

Shortage data has a few known gaps:

  • Lag. FDA lists a shortage after it has confirmed it, so early problems may show up on ASHP first.
  • Manufacturer-supplied details. Reasons and recovery dates usually come from the companies and are not always specific.
  • Product-level records. The openFDA endpoint counts presentations, so a raw record count overstates the number of drugs affected.
  • Coverage. FDA's database covers drugs regulated by CDER, and some biologics regulated by CBER are handled through CBER's own shortage pages on fda.gov.

None of these sources tells you what to do about a shortage for a particular patient. That is a question for the prescriber and pharmacist, who can see local supply and suitable alternatives.

For a wider tour of the free databases that cover drugs, including approvals, labels, safety reports and spending, see the best free drug databases.

Frequently asked questions

Where is the official FDA drug shortage list?
FDA publishes it in its Drug Shortages Database at dps.fda.gov/drugshortages, searchable by generic name or active ingredient.
Why does ASHP list more shortages than FDA?
ASHP uses broader criteria and counts any supply problem that affects how pharmacies prepare or dispense a drug, while FDA lists shortages where national supply does not meet demand.
Does a shortage mean every version of a drug is unavailable?
No. A shortage entry usually lists specific presentations by NDC, and other strengths, package sizes or manufacturers may still be available.
Can a drug be in shortage without a recall?
Yes. Most shortages come from manufacturing problems, demand spikes or discontinuations, and a recall is only one possible cause.

For information only, not medical, legal or investment advice. Facts about FDA and CMS programs are current as of the publication date; check the linked official source for changes.

Keep reading